Cyclo Therapeutics, Inc. (CYTH) Cash flow
Market cap
$20.73M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Depreciation & amortization | 32,747 | - | - | - | - | - | - | - | - | 12,763 | 16,827 | 19,481 | 19,276 |
| Stock-based compensation | 121,472 | - | 40,000 | 71,920 | 48,200 | 54,050 | 65,205 | 19,400 | - | - | - | 354,056 | - |
| Cash from operations | 185,781 | 58,501 | 556,540 | -631,162 | -1,989,414 | -2,950,938 | -3,062,482 | -3,188,440 | -6,589,487 | -8,540,185 | -15,005,298 | -15,114,241 | -16,185,026 |
| Capital expenditures | -553,784 | 166,172 | -156,922 | -173,880 | -419,239 | -9,343 | -6,856 | -2,959 | -1,324 | -53,127 | -22,500 | -15,086 | -2,420 |
| Cash from investing | -553,784 | -166,172 | -154,922 | -173,880 | -418,539 | 942,935 | 32,203 | 32,940 | 36,132 | -14,048 | 14,822 | 38,170 | -2,420 |
| Repayments of term debt | 23,420 | 44,803 | 39,798 | 57,279 | - | - | - | - | - | - | - | - | - |
| Cash from financing | 388,327 | 3,433 | -155,941 | 3 | 2 | 1 | 3,341,055 | 4,101,939 | 7,119,662 | 18,616,627 | 18,757,074 | 6,778 | 24 |
| Free cash flow | |||||||||||||
| FCF margin (%) |